Group One Trading
ECYT

Group One Trading’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Group One Trading’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-57,200
Closed -$1.02M – 5810
2018
Q3 		$1.02M Sell
57,200
-38,800
-40% -$666K 0.01% 1687
2018
Q2 		$1.32M Sell
96,000
-69,400
-42% -$824K 0.01% 1445
2018
Q1 		$1.5M Sell
165,400
-39,800
-19% -$220K 0.02% 1207
2017
Q4 		$878K Sell
205,200
-19,100
-9% -$91K 0.01% 1823
2017
Q3 		$316K Buy
224,300
+76,400
+52% +$106K ﹤0.01% 2425
2017
Q2 		$222K Buy
+147,900
New +$318K ﹤0.01% 2575
2017
Q1 		– Sell
-300
Closed -$1K – 5252
2016
Q4 		$1K Sell
300
-1,900
-86% -$5.46K ﹤0.01% 4355
2016
Q3 		$7K Buy
+2,200
New +$6.86K ﹤0.01% 4160
2016
Q2 		– Sell
-15,500
Closed -$48K – 5149
2016
Q1 		$48K Sell
15,500
-500
-3% -$1.63K ﹤0.01% 3277
2015
Q4 		$64K Buy
16,000
+2,800
+21% +$12.9K ﹤0.01% 3274
2015
Q3 		$60K Sell
13,200
-9,500
-42% -$49.7K ﹤0.01% 3418
2015
Q2 		$118K Buy
22,700
+2,700
+14% +$16.2K ﹤0.01% 2954
2015
Q1 		$125K Sell
20,000
-62,100
-76% -$358K ﹤0.01% 2732
2014
Q4 		$516K Sell
82,100
-226,500
-73% -$1.38M 0.01% 1538
2014
Q3 		$1.88M Sell
308,600
-61,200
-17% -$418K 0.03% 725
2014
Q2 		$2.44M Buy
369,800
+173,400
+88% +$1.95M 0.04% 586
2014
Q1 		$4.68M Buy
196,400
+165,000
+525% +$2.39M 0.08% 252
2013
Q4 		$336K Sell
31,400
-24,500
-44% -$271K 0.01% 1978
2013
Q3 		$745K Buy
55,900
+47,900
+599% +$757K 0.01% 1247
2013
Q2 		$105K Buy
+8,000
New +$108K ﹤0.01% 2772

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Group One Trading's ECYT Position: Q4 2018 in Review

Group One Trading sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 29,231 shares — an estimated $519K sold.

Group One Trading first reported a position in ECYT in Q2 2013 and held it in 11 quarters. The position peaked at $891K in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Group One Trading reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Group One Trading sold 29,231 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $519K.
  • Group One Trading first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Endocyte, Inc. Common Stock position peaked at $891K in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.